Browse studies

Find your next paid study

27,370 recruiting studies available now

Cognixion Pass Through Study

The goal of this study is refine the usability of a BCI capable communication platform. The study will take place in the United States area and will enroll up…

ALS (Amyotrophic Lateral Sclerosis)TBI Traumatic Brain InjurySCI - Spinal Cord Injury+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

CognixionNCT07209943

Phase 2

Phase II Trial of Targeted Radiation With no Castration for Mcrpc

This trial tests if the combination of comprehensive metastasis directed therapy delivered by a precision form of external beam radiotherapy (stereotactic abla…

Prostate Cancer

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06084338

Observational

Beliefs and Attitudes for Successful Implementation in Schools (BASIS) Optimization

The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study test…

Mental HealthHealth ServicesEvidence Based Programs in Schools

Estimated

~$10 – $750

Actual pay is set by the research site.

University of WashingtonNCT06672835

Phase 1

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) - a Phase Ib Feasibility Trial

This is a phase 1b prospective, single arm, open-label trial determining the efficacy and feasibility of using a response-guided approach to help guide neoadju…

Gastroesophageal Adenocarcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, IrvineNCT05733689

Phase 1

CC-486 and Venetoclax for Acute Myeloid Leukemia

This is an open label, dose escalation Phase I single institution pilot study for relapsed and refractory AML patients using CC-486 (oral azacitidine) with ven…

AML

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Colorado, DenverNCT05287568

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Investigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Or…

Oropharyngeal CancerHPV-Related Carcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

H. Lee Moffitt Cancer Center and Research InstituteNCT06305676

Phase 1

A Randomized, Placebo Controlled Proof of Principle (Window of Opportunity) Study of Hydroxychloroquine (HCQ) in Prostate Cancer Patients Undergoing Radical Prostatectomy

This is randomized, double blind, placebo controlled proof of principle (window of opportunity) study of oral hydroxychloroquine in patients with resectable lo…

Resectable Localized Prostate Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Lionel.D.Lewis, MDNCT06408298

Phase 1

Phase 1 Dose-escalation Trial of OMTX705, an Anti-fibroblast Activation Protein Antibody-drug Conjugate, as Single Agent and in Combination With Anti-PD-1 in Patients With Advanced Solid Tumors

Open-label, two parallel arm, multicenter, Phase 1 dose-escalation study to evaluate the safety and tolerability of OMTX705, both as monotherapy or in combinat…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Oncomatryx Biopharma S.L.NCT05547321

Phase 4

CVD 38000: Immunity, Microbiome, Epigenetics, and a Systems Biology Approach to the Study of Responses to Vaccination With Typhoid and/or Cholera

This is an open-label, non-randomized study. The purpose of this study is to better understand how vaccines against typhoid fever and cholera affect the normal…

Typhoid and/or Cholera Vaccination

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT03705585

Observational

Ocular Blood Flow Imaging for Glaucoma Assessment

The goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Me…

Glaucoma

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT05726058

Phase 2

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

To study possible biomarkers that may be related to how SAR444881 works (either alone or when combined with cemiplimab) in participants with solid tumors.

Solid Tumors

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06651593

Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT06541249